The U.S. Food and Drug Administration is recalling more than 89,000 bottles of nasal spray because they might cause "adverse" ...
During an anti-drug awareness seminar in Bandlaguda on Tuesday, the TGANB director Sandeep Shandilya urged the people to work ...
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...
Boston.com on MSN12d
F.D.A. Approves Drug to Treat Pain Without Opioid EffectsThe drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
TWO wild-eyed Zombie-like men sway on a bridge above a dual carriageway as morning commuters gasp in horror. Naked men are ...
Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk. A new study indicates that the ...
I met Omani researcher Dr Mohammed al Husseini at the Muscat Global Knowledge Dialogue hosted by the Sultanate of Oman. We ...
When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...
The company, however, is a shell business owned by one of San Diego's major fentanyl dealers, Algernon Lundy, who in November ...
1d
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results